跳至主要内容
临床试验/NCT03479853
NCT03479853已完成不适用

Clinical, Meibographic and Interferometric Evaluation of Phlyctenular Keratitis in Children - MEIBO-ROSACEE

Fondation Ophtalmologique Adolphe de Rothschild1 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2018年4月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
102
试验地点
1
主要终点
Number of abortive blinks

研究概览

简要总结

The aim of this study is to describe the clinical, meibographic and interferometric manifestations of phlyctenular keratitis in children.

详细描述

The investigators are conducting a monocentric, transversal, epidemiologic study. 100 patients should be included: 50 children suffering from ocular rosacea, and 50 children with no palpebral or Meibomian disease. Witnesses will be matched on the age of the cases.

Patient and controls will undergo a classic ophthalmologic examination with visual acuity measurement and slit lamp examination of both eyes and eyelids. Then, the child will go through a meibographic and interferometric evaluation of his two inferior eyelids. This evaluation is made by an optometrist with the Lipiview device, and lasts a few minutes.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
2 Years 至 16 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Recruited from a specialized ophthalmologic consultation Rothschild Ophthalmologic Foundation, Paris, France.
  • Cases : suffering from ocular or oculo-cutaneous rosacea
  • Witnesses : without any present or past palpebral or meibomian disease

排除标准

  • Unable to achieve the meibographic and interferometric examination (Lipiview)

结局指标

主要结局

Number of abortive blinks

时间窗: Day of inclusion

Number of abortive blinks during the Lipiview exam

Clinical severity

时间窗: Day of inclusion

Clinical severity is determined with a composite score, by the presence of chalazia, corneal lesions, neovascularization, phlyctena, loss of vision, superficial keratitis, anterior and posterior keratitis, meibomitis, palpebral margin keratinization, lagophthalmos, long term use of azithromycin treatment, treatment by ciclosporin eyedrops, intense cutaneous or ocular symptoms, long time evolution of the disease.

Meibographic severity

时间窗: Day of inclusion

The meibographic severity is determined by the level of Meibomian gland atrophy, data obtained with the Lipiview

Interferometric severity

时间窗: Day of inclusion

The interferometric severity is evaluated by the thickness of the lipid layer tear film, data obtained with the Lipiview

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验